Practice of Ventilation in Middle-Income Countries
Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Jun 14, 2017
Trial Information
Current as of July 01, 2025
Completed
Keywords
ClinConnect Summary
Rationale: scarce information exists on management of mechanical ventilation in intensive care unit (ICU) patients in low- and middle-income countries.
Objective:The primary objective is to describe and compare ventilation management in patients at risk of ARDS versus individuals not at risk, and patients with established ARDS, and to ascertain whether certain ventilation settings are associated with a higher incidence of developing ARDS in patients in ICUs in Asia. PRoVENT-iMIC secondary objectives are to determine the epidemiological characteristics and clinical outcomes of patients at r...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Admitted to an ICU participating in this study
- • Intubated in the ICU, or in the emergency room, general ward, or operation room before the present ICU admission
- Exclusion Criteria:
- • Age \< 18 years
- • Patients under invasive mechanical ventilation previous to the 28-day period of inclusion
- • Patients transferred from another hospital under invasive mechanical ventilation
- • Receiving only non-invasive ventilation (i.e., patient never received invasive ventilation during the present admission)
About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)
The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, , Thailand
Dhaka, , Bangladesh
Bangalore, , India
Chittagong, , Bangladesh
Kuala Lumpur, , Malaysia
Chiang Mai, , Thailand
Hanoi, , Vietnam
Ho Chi Minh City, , Vietnam
Tehran, , Iran, Islamic Republic Of
Dhaka, , Bangladesh
Colombo, , Sri Lanka
Raurkela, Odisha, India
Galle, , Sri Lanka
Dhaka, , Bangladesh
Rajshahi, , Bangladesh
Sylhet, , Bangladesh
Pune, , India
Tehran, , Iran, Islamic Republic Of
Tehrān, , Iran, Islamic Republic Of
Johor Bahru, , Malaysia
Kuala Lumpur, , Malaysia
Kuantan, , Malaysia
Malè, , Maldives
Katmandou, , Nepal
Faisalābad, , Pakistan
Islamabad, , Pakistan
Islamabad, , Pakistan
Karachi, , Pakistan
Karachi, , Pakistan
Karachi, , Pakistan
Lahore, , Pakistan
Lahore, , Pakistan
Nawabshah, , Pakistan
Peshawar, , Pakistan
Batticaloa, , Sri Lanka
Colombo, , Sri Lanka
Colombo, , Sri Lanka
Colombo, , Sri Lanka
Colombo, , Sri Lanka
Colombo, , Sri Lanka
Colombo, , Sri Lanka
Jaffna, , Sri Lanka
Puttalam, , Sri Lanka
Bangkok, , Thailand
Bangkok, , Thailand
Bangkok, , Thailand
Bangkok, , Thailand
Chiang Mai, , Thailand
Chiang Mai, , Thailand
Hat Yai, , Thailand
Ongkharak, , Thailand
Patients applied
Trial Officials
Marcus J Schultz, MD, PhD
Principal Investigator
Department of Intensive Care, Academic Medical Center, University of Amsterdam
Arjen M Dondorp, MD, PhD
Principal Investigator
Mahidol Oxford Research Unit, University of Oxford
Luigi Pisani, MD
Study Director
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Ary Serpa Neto, MD, MSc
Study Chair
Hospital Israelita Albert Einstein
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials